<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-07-20)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-07-20)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>Sarepta’s crisis week; Prasad overrides reviewers again; A new study’s clues about Alzheimer’s; and more</h3>
<p class='source-date'><em>Endpoints News • 2025-07-19</em></p>
<p>Welcome back to another edition of Endpoints Weekly! I’m flying solo this week as my recap partner Nicole DeFeudis is on vacation for her wedding! I can speak for all of us here at Endpoints ...</p>
<p><a href='https://endpoints.news/sareptas-crisis-week-prasad-overrides-reviewers-again-a-new-studys-clues-about-alzheimers-and-more/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Sarepta says it won't pull Duchenne gene therapy, setting up showdown with FDA</h3>
<p class='source-date'><em>Endpoints News • 2025-07-19</em></p>
<p>Sarepta Therapeutics said it won't comply with an FDA request to stop shipping the company's treatment for Duchenne muscular dystrophy, following two patient deaths, likely setting up a high-profile battle with the agency over the ...</p>
<p><a href='https://endpoints.news/sarepta-says-it-wont-pull-duchenne-gene-therapy-setting-up-showdown-with-fda/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>GenesisM Breaks Ground on its New Biomanufacturing Facility in the Greater Boston Area</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-18</em></p>
<p>The facility, which is designed to support multiple tenants operating independently within regulated manufacturing suites, will feature 27-foot ceiling heights, up to 18 loading berths, and 40' x 40' column spacing. The post GenesisM Breaks Ground on its New Biomanufacturing Facility in the Great...</p>
<p><a href='https://www.genengnews.com/topics/bioprocessing/genesism-breaks-ground-on-new-biomanufacturing-facility-in-greater-boston-area/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Genetic Disruption of Vitamin D Metabolism Gene Selectively Kills Cancer Cells In Vitro</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-18</em></p>
<p>In vitro studies established SDR42E1 as a key modulator of vitamin D-related pathways, and highlighted its potential as a therapeutic target for addressing vitamin D deficiency and associated pathologies. The post Genetic Disruption of Vitamin D Metabolism Gene Selectively Kills Cancer Cells <i>I...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/vit-d-uptake-gene-discovery-could-lead-to-precision-medicine-applications-including-cancer-therapy/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Undruggable No More: AI Hits Disordered Proteins, Unlocks Therapy Targets</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-18</em></p>
<p>David Baker’s Nobel Prize-winning lab has successfully designed high affinity binders to previously "undruggable" disordered proteins, thereby expanding therapeutic access to over 50% of the human proteome implicated in a wealth of disease pathways, including cancer and neurological disease. The ...</p>
<p><a href='https://www.genengnews.com/topics/artificial-intelligence/undruggable-no-more-ai-hits-disordered-proteins-unlocks-therapy-targets/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Chemical Tweak to Lipid Nanoparticles Cuts Side Effects, Boosts mRNA Potency</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-18</em></p>
<p>Adding phenol groups to the ionizable lipid, a key building block of lipid nanoparticles, curbs inflammatory responses and makes mRNA therapies and vaccines more efficient. The post Chemical Tweak to Lipid Nanoparticles Cuts Side Effects, Boosts mRNA Potency appeared first on GEN - Genetic Engine...</p>
<p><a href='https://www.genengnews.com/topics/genome-editing/chemical-tweak-to-lipid-nanoparticles-cuts-side-effects-boosts-mrna-potency/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<p>No recent microbiome news available today.</p>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Industrialized diets modulate host eating behavior via the microbiome-gut-brain axis.</h4>
<p class='source-date'><em>Liow Yi Jia, Sarkar Amar, Carmody Rachel N | Trends in endocrinology and metabolism: TEM • 2025-07-17</em></p>
<p><strong>Abstract:</strong> The gut microbiome is an important participant in the gut-brain axis and a key mediator of host-diet interactions that shape feeding behavior. These effects occur through microbial metabolism of dietary components - fiber, sugar, fat, and protein - into bioactive metabolites that influence microb...</p>
<p><a href='https://doi.org/10.1016/j.tem.2025.06.002' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Progress and gaps in antimicrobial resistance research within One Health sectors in China: a systematic analysis.</h4>
<p class='source-date'><em>Chen Cai, Li Shu-Le, Liu Jue et al. | Science China. Life sciences • 2025-07-16</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance (AMR) presents a multifaceted health threat to humans, animals, plants, food systems, and environments. In response, China initiated extensive research to understand and address AMR. However, there has been a lack of analysis and synthesis of research results at the natio...</p>
<p><a href='https://doi.org/10.1007/s11427-025-2955-6' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Double-edged sword effect of Sutterella in neurological disorders: Implications for the gut-brain axis and neuroimmune interactions.</h4>
<p class='source-date'><em>Davoody Samin, Halimi Hossein, Zali Alireza et al. | Neurobiology of disease • 2025-07-16</em></p>
<p><strong>Abstract:</strong> The genus Sutterella, a group of bile-resistant, microaerophilic gram-negative bacteria, has emerged as a key player in gut-brain axis communication, with significant yet complex implications for neurological and psychiatric disorders. This study synthesizes current evidence on Sutterella's dual ...</p>
<p><a href='https://doi.org/10.1016/j.nbd.2025.107032' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Biphasic bactericidal activity of nitroxoline against Acinetobacter baumannii assessed by Raman-DIP.</h4>
<p class='source-date'><em>Yi Xiaofei, Chen Xin, Wang Minggui et al. | Journal of microbiological methods • 2025-07-16</em></p>
<p><strong>Abstract:</strong> The increasing antimicrobial resistance (AMR) of Acinetobacter baumannii presents a challenge to clinical management and underscores its role as a critical pathogen in refractory urinary tract infections (UTIs). Nitroxoline has gained renewed interest as a potential therapeutic option. Raman deut...</p>
<p><a href='https://doi.org/10.1016/j.mimet.2025.107199' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Improved lytic action of engineered phage-encoded endolysin and docking insights into its action on bacterial peptidoglycan.</h4>
<p class='source-date'><em>Rani Ruma, Poria Vikram, Jaglan Anu Bala et al. | International journal of biological macromolecules • 2025-07-16</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance in Salmonella poses significant threats, and engineered endolysins offer a promising alternative to traditional bacteriophage therapy. This study focuses on designing, developing, and evaluating a bacteriophage-derived engineered endolysin with a polycationic nonapeptide ...</p>
<p><a href='https://doi.org/10.1016/j.ijbiomac.2025.146105' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<p>No recent papers on Synthetic & Molecular Biology available today.</p>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>M13 bacteriophage as a versatile platform for the creation of new materials via genetic engineering.</h4>
<p class='source-date'><em>de Medeiros Dantas Julia Maria, Kabir Reefah Fahmida, Modafferi Daniel et al. | Canadian journal of microbiology • 2025-07-17</em></p>
<p><strong>Abstract:</strong> M13 bacteriophages form self-assembled nanorods with the ability to self-assemble into complex materials with higher-order structures. These features make them useful templates for material fabrication. Their use in soft materials, bio-nano systems, and biomedical applications is well established...</p>
<p><a href='https://doi.org/10.1139/cjm-2025-0019' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Effects of bacteriophage supplementation on performance, gut health and blood biochemistry in broilers challenged with necrotic enteritis.</h4>
<p class='source-date'><em>Muneeb Muhammad, Khan Ehsaan Ullah, Suleman Muhammad et al. | Research in veterinary science • 2025-07-13</em></p>
<p><strong>Abstract:</strong> Necrotic enteritis (NE), primarily caused by Clostridium perfringens (CP) type G, poses a significant threat to broiler health and performance, especially in antibiotic-restricted production systems. Bacteriophage therapy is emerging as a promising alternative to antibiotics for controlling enter...</p>
<p><a href='https://doi.org/10.1016/j.rvsc.2025.105809' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Improved lytic action of engineered phage-encoded endolysin and docking insights into its action on bacterial peptidoglycan.</h4>
<p class='source-date'><em>Rani Ruma, Poria Vikram, Jaglan Anu Bala et al. | International journal of biological macromolecules • 2025-07-16</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance in Salmonella poses significant threats, and engineered endolysins offer a promising alternative to traditional bacteriophage therapy. This study focuses on designing, developing, and evaluating a bacteriophage-derived engineered endolysin with a polycationic nonapeptide ...</p>
<p><a href='https://doi.org/10.1016/j.ijbiomac.2025.146105' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Macrocyclic Phage Display for Identification of Selective Protease Substrates.</h4>
<p class='source-date'><em>Faucher Franco F, Blažková Kristýna, Lovell Scott et al. | Journal of the American Chemical Society • 2025-07-18</em></p>
<p><strong>Abstract:</strong> Traditional methods for identifying selective protease substrates have primarily relied on synthetic libraries of linear peptides, which offer limited sequence and structural diversity. Here, we present an approach that leverages phage display technology to screen large libraries of chemically mo...</p>
<p><a href='https://doi.org/10.1021/jacs.5c04424' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Structural mechanisms behind the neutralisation of long-chain α-neurotoxins by broadly neutralising V</h4>
<p class='source-date'><em>Damsbo Anna, Burlet Nick J, Fernández-Quintero Monica L et al. | Communications chemistry • 2025-07-19</em></p>
<p><strong>Abstract:</strong> Snakebite envenoming, a neglected tropical disease, affects millions globally, causing significant morbidity and mortality. Developing broadly neutralising monoclonal antibodies offers a promising approach to address the antigenic variation present in snake venoms. In this study, we designed a lo...</p>
<p><a href='https://doi.org/10.1038/s42004-025-01600-4' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<p>No recent papers on Skin Microbiome & Disease available today.</p>
<hr>
<p><em>Report generated on 2025-07-20</em></p>
</div>
</body>
</html>